Figure 6

Kaplan-Meier survival curves (left) and ROC curves (right) to evaluate the five-miRNA prognostic signature in the training set (A) and the validation set. (B) Patients are separated into a high-risk group and a low-risk group by risk score.

Kaplan-Meier survival curves (left) and ROC curves (right) to evaluate the five-miRNA prognostic signature in the training set (A) and the validation set. (B) Patients are separated into a high-risk group and a low-risk group by risk score.